Recent News
Chengdu Frontier BioSciences of China Selects Pristima For Preclinical Data Management
Pristima Suite Is Key To Frontier’s Goal of Becoming Preeminent... Read more
Frontier BioSciences, Inc., (Frontier) has hired Joseph J. Stashick, RQAP-GLP as the new Director of Quality Assurance
Frontier is pleased to announce the addition of Joseph J. Stashick,... Read more
Frontier BioSciences Appoints Mark Walker a Senior Post at its China Facility
Frontier is pleased to announce the addition of Mark D. Walker, DVM as... Read more
Expertise
Frontier BioSciences, Inc. is a leading global contract research organization (CRO) providing drug discovery, development, and regulatory guidance in China. Our clients and partners include biotechnology, pharmaceutical, medical device, academic, and government organizations. With toxicology laboratories in Chengdu and Kunming in China and partnership with West China (Huaxi) Hospital, Frontier applies international CRO experience, therapeutic expertise, and commitment to quality to assist our clients and partners in delivering their drugs to market.
Services
Why Frontier BioSciences, Inc.?
- Staff with international CRO & big pharma experience
- Staff members on the SFDA IND/NDA review board
- AAALAC International-accredited
- Contracts with U.S. government agencies (DoD, DHHS/NIAID/BARDA)
- Most comprehensive NHP historical database in China
- Partnership with West China (Huaxi) Hospital, largest hospital in Asia
- U.S. FDA accepted data
Contact us to learn more.